Research Article

Complementary and Alternative Medicine Use and Its Determinant Factors in Iranian Asthma and Chronic Obstructive Pulmonary Disease Patients

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are the most common chronic diseases with a high global burden of disease. Today, the use of complementary and alternative medicine (CAM) has become more popular. In general, in developing countries, easy access and low cost of traditional medicine, and in developed countries, more access to health information, the prevalence of old age and the increase in chronic diseases are the reasons for this increasing use of traditional medicine. This study aimed to determine the rate and pattern of CAM used and their relationships with demographic characteristics among asthmatic and COPD patients. This research was a cross-sectional study performed on asthma and COPD patients (n=357) referring to the Pulmonary Diseases affiliated with Ardabil University of Medical Sciences, Ardabil, Iran from 2019 to 2020. Data were collected by using semi-structured questionnaires including open and closed questions and face-to-face interviews. Three hundred and thirty-nine patients (95%) used at least one type of CAM in the last year of study. About half of the patients (49.9%) used more than two types of CAM during the last 12 months. Three hundred and four patients (85.2%) used medicinal plants. Few patients reported with the use of CAM to their physician or health care providers (16.1%, 12.5%, and 16.7% of the users of medicinal plants, bloodletting, and dry cupping respectively). Relatives and friends (77.9%) were with the most common sources of recommendation of CAM to the patients. The present study showed the high prevalence of using different types of CAM, especially herbal medicines in Iranian asthmatic and COPD patients. The main incentive for using CAM was for friends and family members, not health care providers. The use of CAM is associated with age patients age, family size, habitat, education, and occupation.

Viegi G, Maio S, Fasola S, Baldacci S. Global burden of chronic respiratory diseases. J Aerosol Med Pulm Drug Deliv 2020;33:171-177.

Akinci AC, Zengin N, Yildiz H, Sener E, Gunaydin B. The complementary and alternative medicine use among asthma and chronic obstructive pulmonary disease patients in the southern region of Turkey. Int J Nurs Pract 2011;17:571-582.

Flexeder C, Hassan LK, Standl M, Schulz H, Kühnisch J. Is there an association between asthma and dental caries and molar incisor hypomineralisation? Caries Res 2020;54:87-95.

Lim JU, Lee JH, Kim JS, Hwang YI, Kim T-H, et al. Comparison of world health organization and asia-pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis 2017;12:2465.

Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020;8:585-596.

Bastani F, Farajtabar F. Assessment of insomnia severity in elderly patients with chronic obstructive pulmonary disease in rasoul akram hospital, 2019 Tehran. J Ardabil Uni Med Sci 2020;20:20-31.

Ostovar A, Fokkens WJ, Pordel S, Movahed A, Ghasemi K, et al. The prevalence of asthma in adult population of southwestern Iran and its association with chronic rhinosinusitis: a GA2LEN study. Clin Transl Allergy 2019;9:1-7.

Sharifi H, Masjedi MR, Emami H, Ghanei M, Eslaminejad A, et al. Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease. Lung India 2015;32(6):572-577.

Orhan F, Sekerel BE, Kocabas CN, Sackesen C, Adalioglu G, et al. Complementary and alternative medicine in children with asthma. Ann Allergy Asthma Immunol 2003;90:611-615.

Shukla D, Chakraborty S, Singh S, Mishra B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2009;10:2343-2356.

Tho NV, Park HY, Nakano Y. Asthma–COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology 2016;21:410-418.

Sahin ZA, Sahin M. The view of patients with chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine (CAM) in eastern Turkey. Afr J Tradit Complement Altern Med 2013;10:116-121.

Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008:1-23

Astin JA, Pelletier KR, Marie A, Haskell WL. Complementary and alternative medicine use among elderly persons: one-year analysis. J Gerontol Med Sci 2000;55:M4-9.

Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Int Med 2002;162:281-287.

Rostami Chijan M, Salehi M, Ostovar M, Haghjoo E, Sedigh Rahimabadi M, et al. The I-CAM-IR: persian translation, cross-cultural adaptation and revised version of the I-CAM-Q. Trad Integr Med 2022;7:432-443..

Anbari K, Gholami M. Evaluation of trends in the use of complementary and alternative medicine in health centers in Khorramabad (west of Iran). Glob J Health Sci 2016;8:72-76.

Yekta Z, Zamani A, Mehdizade M, Farajzadegan Z. Pattern of complementary and alternative medicine use in urban population. J Res Health Sci 2007;7:24-31.

Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Alternat Complement Med 2006;12:805-812.

Argüder E, Bavbek S, Şen E, Köse K, Keskin Ö, et al. Is there any difference in the use of complementary and alternative therapies in patients asthma and COPD? A cross-sectional survey. J Asthma 2009;46:252-258.

Abolhassani H, Naseri M, Mahmoudzadeh S. A survey of complementary and alternative medicine in Iran. Chin J Integr Med 2012;18:409-416.

Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 2007;16:144-149.

Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey. BMC Complement Altern Med 2013;13:1-9.

Heidarnazhad H, Tavasoli S. Beliefs, perceptions and practices about asthma among Iranian asthma patients. East Mediterr Health J 2009;15:912-919.

Vakili M, Modarresi M, Zare A, Rahmaninejad M. Study of motivation and satisfaction rate in patients presenting fir blood–letting in Yazd 2014. J Islam Iran Tradit Med 2016;7:333-337.

Abd al-Jawad MEM, Mohamed S, Elsayed B, Mohamed A. Evaluation of wet cupping therapy (Hijama) as an adjuvant therapy in the management of bronchial asthma. Indian J Physiother Occup Ther 2011;5:122-126.

Alshagga MA, Al-Dubai SA, Faiq SSM, Yusuf AA. Use of complementary and alternative medicine among asthmatic patients in primary care clinics in Malaysia. Ann Thorac Med 2011;6:115-119.

Ceylan S, Hamzaoğlu O, Kömürcü S, Beyan C, Yalcin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med 2002;10:94-99.

Files
IssueVol 8, No 4, 2023 QRcode
SectionResearch Article(s)
DOI https://doi.org/10.18502/tim.v8i4.14486
Keywords
Asthma Chronic obstructive pulmonary disease Complementary therapy plant Persian medicine

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kheirypour A, Moini Jazani A, Hashempur MH, Ghobadi-Marallu H, Nasimi Doost Azgomi R. Complementary and Alternative Medicine Use and Its Determinant Factors in Iranian Asthma and Chronic Obstructive Pulmonary Disease Patients. Trad Integr Med. 2023;8(4):379-388.